Status:
UNKNOWN
PECS Block With Bupivacaine Vs Bupivacaine and Dexmedetomidine in Modified Radical Mastectomy
Lead Sponsor:
Zagazig University
Conditions:
Anesthesia
Eligibility:
FEMALE
21-65 years
Phase:
NA
Brief Summary
The incidence of breast cancer as well as the need for surgical treatment has increased. Breast cancer surgery (BCS) is associated with many complications such as increased incidence of acute and chr...
Detailed Description
Breast cancer is the most frequent cancer among women; it causes the highest number of cancer-related deaths among them globally. The prognosis has improved considerably over the past 30 years, and th...
Eligibility Criteria
Inclusion
- Hospitalized for modified radical mastectomy. American Society of Anesthesiologists (ASA), physical status II. Age between 21-65 year.
Exclusion
- Patient's refusal. Preexisting coagulopathy or anti-coagulant therapy. Local infection at site of injection. Pregnancy or breast feeding. Body Mass Index (BMI) \> 35kg/m². Allergy to local anesthetics and drugs used. Prior breast surgery except for diagnostic biopsies.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04284098
Start Date
March 1 2020
End Date
July 1 2020
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thorya M Salem
Zagazig, Egypt